Skip to content

Clinical safety of allergy-reduced eggs in patients with severe hen's egg allergy

Clinical safety of allergy-reduced eggs in patients with severe hen's egg allergy - Clinical safety of allergy-reduced eggs in patients with severe hen's egg allergy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053816
Enrollment
50
Registered
2024-03-11
Start date
2024-02-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Food allergy

Interventions

Sponsors

NHO Sagamihara National Hospital
Lead Sponsor
Kewpie Corporation Hiroshima university graduate school of integrated sciences for life
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with allergic symptoms to less than one-eighth of a heated hen's egg in oral food challenge.

Exclusion criteria

Exclusion criteria: (1) Patients who received systemic steroid medication (1mg/kg/day or more) for more than 7 days within 3 months prior to the oral food challenge. (2) Patients receiving anti-IgE antibody, anti-IL-5 antibody, anti-IL-5 receptor antibody, anti-IL-4/IL-13 receptor antibody, or JAK inhibitor (oral). (3) Decision of ineligibility by a physician.

Design outcomes

Primary

MeasureTime frame
Percentage of positive results in the oral food challenge using heated ovomucoid-free hen's egg.

Secondary

MeasureTime frame
(1) Egg white-specific IgE level (2) Ovomucoid-specific IgE level (3) Severity of symptoms

Countries

Japan

Contacts

Public ContactRui Ozeki

NHO Sagamihara National Hospital Department of Allergy, Clinical Research Center for Allergy and Rheumatology

rui.ozeki11@gmail.com042-742-8311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026